Disease: Melanoma astrocytoma syndrome
- 9p21.3 Microdeletion involving <em>CDKN2A/2B</em> in a young patient with multiple primary cancers and review of the literature
- A familial syndrome with cutaneous malignant melanoma and cerebral astrocytoma
- A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family
- A large de novo 9p21.3 deletion in a girl affected by astrocytoma and multiple melanoma
- Anti-neuronal nuclear autoantibodies, types 1 and 2: their utility in the study of tumors of the nervous system
- Association of brain tumours with other neoplasms in families
- CDKN2A exon 1B deletion predisposing to melanoma and neural system tumour syndrome
- Clinical and histopathologic features of paraneoplastic granuloma annulare in association with solid organ malignancies: A case-control study
- Cutaneous Melanoma and Glioblastoma Multiforme Association-Case Presentation and Literature Review
- Drug-induced hypersensitivity syndrome following temozolimide for glioblastoma multiforme and the role of desensitization therapy
- Estimated Prevalence, Tumor Spectrum, and Neurofibromatosis Type 1-Like Phenotype of CDKN2A-Related Melanoma-Astrocytoma Syndrome
- Eye Tumors in Childhood as First Sign of Tumor Predisposition Syndromes: Insights from an Observational Study Conducted in Germany and Austria
- Familial aggregation of malignant melanoma/dysplastic naevi and tumours of the nervous system: an original syndrome of tumour proneness
- Familial cutaneous malignant melanoma and tumors of the nervous system. A hereditary cancer syndrome
- Familial melanoma-astrocytoma syndrome: synchronous diffuse astrocytoma and pleomorphic xanthoastrocytoma in a patient with germline CDKN2A/B deletion and a significant family history
- Fast neutron beam radiotherapy at the University of Washington
- Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors
- Hereditary tumor syndromes and gliomas
- Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
- Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma
- Lack of inherited mutations of PTPRD in familial melanoma and melanoma-astrocytoma syndrome
- Malignant Peripheral Nerve Sheath Tumor in a Patient With BAP1 Tumor Predisposition Syndrome
- Multiple neurofibromas as the presenting feature of familial atypical multiple malignant melanoma (FAMMM) syndrome
- Newly Recognized Genetic Tumor Syndromes of the CNS in the 5th WHO Classification: Imaging Overview with Genetic Updates
- Nuclear karyopherin a2: a novel biomarker for infiltrative astrocytomas
- OMICS and biomarkers of glial tumors
- p53 Germline mutation in a patient with Li-Fraumeni Syndrome and three metachronous malignancies
- Pineal region surgery. Experience in 22 patients
- Point mutation in p14<sup>ARF</sup> -specific exon 1β of CDKN2A causing familial melanoma and astrocytoma
- Second malignant neoplasms following the treatment of brain tumors in children
- Secondary vasoproliferative retinal tumor associated with Usher syndrome type 1
- Shoulder-hand syndrome in patients with intracranial neoplasms
- The genetics of hereditary melanoma and nevi. 1998 update
- Tolerance of normal human brain to boron neutron capture therapy